Ingredient Evidence Review
L-Arginine in Nitric Boost Ultra
Detailed review of L-arginine in Nitric Boost Ultra, including erectile-function research, studied doses, nitric oxide biology and product-specific dose limitations.
Save or follow this source
Add Male Performance Supplements to Google Preferred Sources or open this page in your preferred AI tool.
Desk ResearchEvidence LabelsSafety ContextUpdated Aug
Published Products
Explore all current MPS evidence-led product reviews.
Why it is included
L-arginine has one of the clearest evidence links in the formula.
L-arginine is an amino acid that can serve as a substrate for nitric oxide synthase. Because nitric oxide is important to vascular smooth-muscle relaxation and normal erectile physiology, oral arginine has been studied in men with erectile dysfunction.
A 2019 systematic review and meta-analysis evaluated randomized trials of arginine in mild-to-moderate erectile dysfunction. Across heterogeneous interventions, the authors reported improvements for several outcomes compared with placebo or no treatment. Studied oral amounts were generally in the approximate 1.5–5 g/day range.
That evidence makes L-arginine relevant. It does not establish that Nitric Boost Ultra reproduces those interventions, because the product's exact L-arginine amount has not been sufficiently verified from the current material reviewed.
Evidence interpretation
What the human studies do—and do not—tell us.
Supports relevance
Human trial literature exists
Unlike ingredients supported mainly by laboratory or animal data, arginine has direct human erectile-function research and systematic-review coverage.
Limits transfer
Dose and formulation still matter
A product cannot be assumed equivalent to a trial unless the amount, form, combination and target population are sufficiently comparable.
MPS evidence grade: moderate relevant evidence for L-arginine in selected ED contexts; Nitric Boost Ultra-specific effectiveness remains unestablished.
Arginine + citrulline
Why the pairing is biologically coherent.
Oral arginine undergoes substantial first-pass metabolism. Citrulline follows a different pathway and can be converted into arginine, which is one reason the two compounds are often discussed together in nitric-oxide supplementation.
That pairing can support a mechanism hypothesis. It does not establish that an unspecified ratio or amount in a multi-ingredient formula is clinically optimized.
Safety context
Vascular relevance also means medication context matters.
Because arginine is linked with nitric-oxide and vascular pathways, people taking blood-pressure or cardiovascular medicines should not assume combination use is automatically appropriate. Individualized clinical advice is especially useful when multiple agents influence blood pressure or circulation.
L-arginine evidence map: ingredient relevance versus finished-product proof
The page already shows why L-arginine is relevant to nitric-oxide biology. The stronger product question is whether the finished formula delivers a verifiable amount and whether ingredient-level evidence can reasonably be applied to Nitric Boost Ultra itself.
| Evidence layer | What can be said | What remains uncertain |
|---|---|---|
| Mechanistic relevance | L-arginine is directly related to nitric-oxide synthesis. | A plausible mechanism does not establish a finished-product benefit. |
| Human studies | Human evidence can inform whether arginine affects selected vascular outcomes. | Results should not be generalized beyond the studied population, dose and outcome. |
| Formula pairing | Arginine can be discussed alongside citrulline and nitrate-related ingredients. | Biological coherence is not the same as clinical proof for the combined formula. |
| Product interpretation | Ingredient identity supports plausibility. | Product-level efficacy still depends on dose transparency and direct evidence. |
Interpretation: L-arginine strengthens the rationale for the formula, but it does not by itself establish that Nitric Boost Ultra produces the claimed outcome.
Selected references
Research trail
- Rhim HC, Kim MS, Park YJ, et al. Arginine supplements and erectile dysfunction: systematic review and meta-analysis. PubMed PMID 30770070.
- Xu Z, Liu C, Liu S, Zhou Z. L-arginine and PDE5 inhibitors in erectile dysfunction: systematic review/meta-analysis. PubMed PMID 33587304.
- NIH Office of Dietary Supplements: Exercise and Athletic Performance.
- Current merchant/product materials supplied for this project, reviewed August 21, . Product formulation, prices, bonuses and guarantee statements are treated as merchant representations rather than independent efficacy evidence.
References are included for research context. Evidence on a constituent ingredient does not automatically validate the finished product.
Current merchant offer
Compare the current Nitric Boost Ultra package options.
The supplied merchant materials reviewed August 21, show one-, three- and six-jar packages. Commercial terms can change; verify the live checkout before purchasing.
1 Jar · 30 Days
$69 total · $69/jar
Shipping additional in the supplied offer.
6 Jars · 180 Days
$294 total · $49/jar
Free U.S. shipping + two digital bonuses currently displayed.
3 Jars · 90 Days
$177 total · $59/jar
Free U.S. shipping + two digital bonuses currently displayed.
Continue the research
Explore the Nitric Boost Ultra evidence cluster.
Safety & mechanism
Ingredient deep dives
L-Arginine →
L-Citrulline →
Beet Root →
D-Aspartic Acid →
Horny Goat Weed →